Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

Spread the love Introduction The biotechnology industry continues to be at the forefront of scientific innovation, driving ...

CRISPR Therapeutics’ Julianne Bruno is hitting the exit in favor of external opportunities, marking the latest shakeup to the ...

A new CRISPR-based technology, called RIDE, is a leap forward for this trail-blazing technology. With the precision of a ...

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common ...

PHILADELPHIA- A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common chronic ...

CRISPR Therapeutics poised for growth with international potential and clinical assets. Read why I rate CRSP stock a Strong ...

A recently identified bacterial protein structure is contributing to the design of novel anticancer drug delivery systems.

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

Targeted CRISPR lipid nanoparticles eliminated 50% of tumors in mice with head and neck cancer.

Researchers have discovered a handful of new CRISPR-Cas systems that could add to the capabilities of the already transformational gene editing and DNA manipulation toolbox. Of the new recruits, one ...